APA (7th ed.) Citation

Nakamoto, T., Iwamoto, N., Oshiro, Y., Inamura, N., Nemoto, T., Ide, S., . . . Ohmagari, N. (2024). COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production. BMC Infectious Diseases, 24(1), 1. https://doi.org/10.1186/s12879-024-10090-z

Chicago Style (17th ed.) Citation

Nakamoto, Takato, et al. "COVID-19 Severity and Corticosteroid Treatment Have Minimal Effect on Specific Antibody Production." BMC Infectious Diseases 24, no. 1 (2024): 1. https://doi.org/10.1186/s12879-024-10090-z.

MLA (9th ed.) Citation

Nakamoto, Takato, et al. "COVID-19 Severity and Corticosteroid Treatment Have Minimal Effect on Specific Antibody Production." BMC Infectious Diseases, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12879-024-10090-z.